Stocks and Investing Stocks and Investing
Thu, May 7, 2020

David Lebovitz Maintained (ALNY) at Buy with Increased Target to $162 on, May 7th, 2020


Published on 2024-10-27 05:36:05 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $148 to $162 on, May 7th, 2020.

David has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Alan Carr of "Needham" Maintained at Strong Buy with Increased Target to $160 on, Wednesday, May 6th, 2020
  • Christopher Marai of "Nomura" Maintained at Sell and Held Target at $74 on, Tuesday, April 14th, 2020
Contributing Sources